Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Motzer

Showing results (81-90 of 436) with videos related to

Pageof 44
Sort By:
The Journal of Urology|September 23, 2003
Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumorsJoel Sheinfeld, Robert J Motzer, Farhang Rabbani, et al.
Urology|September 19, 2006
Long-term response with sunitinib for metastatic renal cell carcinomaEllen A Ronnen, G Varuni Kondagunta, Michelle S Ginsberg, et al.
European Urology Focus|May 4, 2025
Re: Justine Panian, Caiwei Zhong, Sharon H. Choi, et al. Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.11.011Viktor Grünwald, Thomas Powles, Thomas E Hutson, et al.
Urologic Oncology|November 23, 2005
Late relapse of testicular germ cell tumorsBrett S Carver, Robert J Motzer, Gnanamba Varuni Kondagunta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Targeting von Hippel-Lindau pathway in renal cell carcinomaPremal H Patel, Rajendrakumar S V Chadalavada, R S K Chaganti, et al.
Oncology|June 20, 2015
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with PazopanibMichael W Kattan, Cora N Sternberg, Faisal Mehmud, et al.
The Journal of Urology|September 23, 2003
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testisKamal S Pohar, Farhang Rabbani, George J Bosl, et al.
Urology|December 11, 2003
Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratomaFarhang Rabbani, Hesam Farivar-Mohseni, Antonio Leon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2007
Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratomaBrett S Carver, Bobby Shayegan, Angel Serio, et al.
BJU International|April 18, 2007
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumourBobby Shayegan, Brett S Carver, Jason Stasi, et al.
Pageof 44

Showing results (81-90 of 436) with videos related to

Sort By:
Pageof 44
The Journal of Urology|September 23, 2003
Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumorsJoel Sheinfeld, Robert J Motzer, Farhang Rabbani, et al.
Urology|September 19, 2006
Long-term response with sunitinib for metastatic renal cell carcinomaEllen A Ronnen, G Varuni Kondagunta, Michelle S Ginsberg, et al.
European Urology Focus|May 4, 2025
Re: Justine Panian, Caiwei Zhong, Sharon H. Choi, et al. Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.11.011Viktor Grünwald, Thomas Powles, Thomas E Hutson, et al.
Urologic Oncology|November 23, 2005
Late relapse of testicular germ cell tumorsBrett S Carver, Robert J Motzer, Gnanamba Varuni Kondagunta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Targeting von Hippel-Lindau pathway in renal cell carcinomaPremal H Patel, Rajendrakumar S V Chadalavada, R S K Chaganti, et al.
Oncology|June 20, 2015
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with PazopanibMichael W Kattan, Cora N Sternberg, Faisal Mehmud, et al.
The Journal of Urology|September 23, 2003
Results of retroperitoneal lymph node dissection for clinical stage I and II pure embryonal carcinoma of the testisKamal S Pohar, Farhang Rabbani, George J Bosl, et al.
Urology|December 11, 2003
Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratomaFarhang Rabbani, Hesam Farivar-Mohseni, Antonio Leon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2007
Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratomaBrett S Carver, Bobby Shayegan, Angel Serio, et al.
BJU International|April 18, 2007
Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumourBobby Shayegan, Brett S Carver, Jason Stasi, et al.
Pageof 44